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A 15 to 17-year follow up of the Kinemax Total Knee Replacement 
 
 
1 Introduction 
Total knee replacement (TKR) is a successful and cost effective operation for the 
majority of patients, although up to 20% of patients report an unfavourable long-
term pain outcome [1]. The number of TKR operations performed continues to rise 
year on year and large future increases in demand have been predicted [2]. TKR 
remains the only intervention that has a large effect size for the relief of chronic 
knee pain [3].  
 
There is a paucity of prospective longitudinally collected data available regarding the 
outcome of TKR [4]. Long term follow up studies in excess of 10 years often do not 
include preoperative data or data from the early postoperative period, limiting our 
ability to determine the success of the intervention regarding long term patient 
focused outcomes and whether patient satisfaction and improvements in pain and 
function are maintained in the long term. It has been established that even when 
collected in the early postoperative period, retrospectively recalled patient data 
regarding pain and function is not reliable [5], limiting the utility of this approach. 
 
The aim of this study was to determine the mortality, implant survivorship, patient 
reported function and satisfaction in a cohort of patients who had received a 
Kinemax total knee replacement more than 15 years ago. 
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2 Patients and Methods 
2.1 Patients 
The cohort consisted of 124 Kinemax TKRs (114 patients; 47 males and 67 females) 
performed in our centre between September 1997 and December 1998, there were 
no modifications to the polyethylene during this period. Ten patients had both knees 
replaced during the period of recruitment (5 males and 5 females). Eight of the 
patients had a diagnosis of rheumatoid arthritis and the remainder had a diagnosis 
of osteoarthritis. A medial parapatellar approach was used in all but three cases 
where a subvastus approach was used. Standard cemented femoral and tibial 
components were used in all cases. The patella was resurfaced in all but two cases, 
where patellar debridement only was performed. The mean interval between 
operations in those that had both knees replaced was 3.9 months (range 2.8-6.2). 
There were six deaths during follow up in the group that had both sides replaced 
during the recruitment period and 63 deaths amongst the group that only had one 
side replaced leaving 45 patients alive at final follow up. Four patients were excluded 
from the cohort due to medical comorbidities (dementia in three patients and a 
stroke in one patient). The mean age at surgery in the cohort was 72 years (range 
48.2-89.8). The mean body mass index (BMI) of the patients at the time of surgery 
was 28 (range 17.0-41.1). The mean age of the surviving patients at final follow up 
was 83 years (range 64.4-94.9). 
 
Mortality in the cohort was assessed by a combination of interrogation of hospital 
records and the NHS National Strategic Tracing Service. Revision of the TKR in 
deceased patients was assessed by interrogation of hospital and primary care 
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records. In the surviving patients, the survivorship of the implant was confirmed in 
the postal questionnaire that was completed by the patients. The median time from 
surgery to final follow up in the surviving patients was 15.7 years (IQR 15.4-16.3). 
 
2.2 Outcome measures 
Patients completed a questionnaire preoperatively, at 3 months, 1 year, 2 years and 
a minimum of 15 years following surgery. The questionnaire incorporated disease- 
and joint-specific scores including the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) and Oxford knee score (OKS). The WOMAC is a 24-
item disease-specific measure which includes separate subscales for pain, function 
and stiffness.  Global scores range from 0-96, with 0 being the best score. In this 
study, WOMAC Pain (0-20) and Function (0-68) subscales were collected at all time 
points, and the WOMAC Stiffness (0-8) subscale was collected pre-operatively and at 
3 months and 15 years postoperation. Therefore, WOMAC global scores were 
calculated for these time points. The OKS is a 12-item joint-specific questionnaire 
validated in patients undergoing TKR. Total scores range from 0-48 scale with 48 
being the best score.  Patient satisfaction with the outcome of surgery was assessed 
using the Self-Administered Patient Satisfaction Scale for Primary Hip and Knee 
Arthroplasty (SAPS) and general health was assessed at final follow-up using the EQ-
5D. In addition to these validated outcome measures, patients completed questions 
regarding the occurrence of infection, venous thrombosis, anterior knee pain, 
numbness, periprosthetic fracture, stiffness, revision and any other postoperative 
complications at the final follow up. 
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2.3 Statistics 
A D’Agostino and Pearson normality test was performed to determine the 
distribution of data. Where data were normally distributed, central tendency is 
described with the mean and range. Where data were not normally distributed, the 
median and inter-quartile range (IQR) were used. Kaplan-Meier survivorship analysis 
with 95% confidence intervals (CI) was performed for the endpoints of mortality or 
revision of the TKR. The numbers at risk at each 5-year interval are expressed in 
figures 1 and 2. When a patient had undergone bilateral staged TKRs during the 
recruitment period, the first operation only was considered for the mortality 
analysis. Analysis of non-parametric data over multiple time points was performed 
with a Kruskal-Wallis test with Dunn’s multiple comparison post-tests.  
 
 
3 Results 
The survivorship of the cohort with death as the endpoint was 34.6% (95% CI 24.4-
45.0%) at a follow up of 16.2 years. The median time to death following surgery in 
the deceased patients was 9.0 years (IQR 4.4-12.8).  
 
The survivorship of the cohort with revision of the TKR as the endpoint was 84.4% 
(95% CI 62.8-94.0%) at a follow up of 16.3 years. Four cases were revised for wear of 
the polyethylene liner, three cases for aseptic loosening (femoral and tibial 
component in one case, femoral component only in one case and tibial component 
only in one case) and one case was revised for a femoral component periprosthetic 
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fracture secondary to osteolysis. The mean time until revision in the revised patients 
was 10.0 years (range 2.4-16.3).  
 
Thirty-nine patients out of the 41 included at final follow-up completed the final 
outcome questionnaire (43 out of 45 eligible TKRs). The mean EQ5D score was 0.553 
(range 0-1). The median and interquartile ranges for the WOMAC subscales, global 
score, OKS and SAPS are shown in table 1 and longitudinal plots over time shown in 
figures 3 to 6.  
 
A significant improvement was seen in the WOMAC Pain subscale over time 
(p<0.0001). Dunn’s post-test revealed significant differences between the 
preoperative score and the postoperative score at 3 months, 1 year, 2 years and a 
mean of 15.7 years (p<0.0001). No significant differences were observed between 
any of the postoperative time points. The same pattern and level of significance was 
observed for the WOMAC Function subscale. The WOMAC Stiffness subscale and 
global score demonstrated a significant improvement between the preoperative 
score and each of the postoperative time points (p<0.0001) but no difference 
between the postoperative time points. 
 
A significant improvement was seen in the OKS over time (p<0.0001). Dunn’s post-
tests revealed significant differences between the preoperative score and the 
postoperative score at 3 months, 1 year, 2 years and 15.7 years (P<0.0001). A 
significant improvement was also seen between 3 months and 1 year postoperation 
(p<0.05) but not at any of the other postoperative time points.  
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A significant change was seen in the SAPS over the postoperative follow up period 
(p=0.012). Dunn’s post-tests revealed no significant differences between the 3 
months score and any of the subsequent time points however a significantly lower 
score was seen at the 15.7 year follow up when compared to the 1 year and 2 year 
postoperation follow ups (p<0.05). At 1 year following surgery, 102 patients of 110 
responders to this part of the questionnaire indicated that overall, they were 
somewhat or very satisfied with the knee replacement. At final follow up, 28 of the 
39 responders indicated that overall, they were somewhat or very satisfied with the 
knee replacement. 
 
When questioned about complications following their TKR at final follow up, 2 out of 
39 responders indicated they had experienced an infection. Neither of these patients 
indicated they had required a delayed discharge, antibiotics or readmission to 
hospital or revision. Five of the 39 responders reported they had experienced a DVT, 
one of which was treated with clexane and the remainder with warfarin. Eleven of 
the 39 responders indicated they had experienced anterior knee pain, none of which 
required any reoperations; five patients indicated they had numbness in association 
with their scar but none reported that this was a concern for them. Other than the 
previously described revision for a periprosthetic fracture, no patient reported a 
fracture and no patient reported they had undergone any intervention for stiffness. 
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4 Discussion 
The mortality of this cohort of patients who received a Kinemax TKR over the period 
studied was similar to that observed in other long term longitudinal studies of TKR 
[6]. The survivorship of the patients reported in this cohort is in keeping with the 
national statistics for the country of origin and the age group of the patients [7]. The 
reported survivorship of the TKRs with revision of the prosthesis as the end point 
was satisfactory for the period reported (84.4% at 16.3 years). These results are 
consistent with the reported survivorship of alternative cemented TKR designs from 
randomised controlled trials [8] and case series [9] with follow up to 15 years. The 
Kinemax TKR has been shown to have a survivorship equivalent to other prosthesis 
designs in the Norwegian registry in the short to medium term (5 years) [10]. In the 
longer term (10 years), the relative risk of revision was shown to be higher for the 
Kinemax TKR than for some alternative designs in the Swedish registry but this may 
be influenced by the known temporal trend to decreased revision rates in the 
Swedish registry and use of the Kinemax stopping in Sweden in 2006 [11]. The 
components in this study were cemented, the survivorship of the uncemented 
Kinemax design has been shown to be inferior to cemented fixation [12]. This may 
not be true for all designs of TKR [8], with one series of uncemented TKR reporting 
implant survival rates of 97.1% at 20 years [13].  
 
The predominant modes of failure observed in the study were wear and loosening, 
which is typical of long term follow up of TKR [6, 14, 15]. Rotational malalignment is 
known to effect implant survivorship [16], but there is no evidence to suggest this 
effects the Kinemax TKR more than other implants. 
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The maintenance of patient reported function in the medium term has been 
reported for the Kinemax TKR [17]. Few long term follow up studies incorporating 
patient reported function and preoperative data are available [4]. Long term follow 
up studies of TKR are often limited by the lack of preoperative or longitudinal patient 
reported functional scores [15]. The results of such long term follow up have shown 
good or excellent function or pain scores in 75-90% of patients. Marked preoperative 
functional limitation, severe pain, low mental health scores and multiple comorbid 
conditions are predictive of short term outcomes following TKR [18]. Short term 
postoperative pain and function may be predicted by different preoperative factors 
[19]. Differences in outcome predicted by baseline psychosocial factors are however, 
not maintained in the medium term [20]. Given the mortality rates in this study, we 
would not have achieved sufficient power to determine if the same effect was 
present in the long term, although the lack of change in the functional outcome 
scores in the long term suggests this may be the case. Due to the limited size of the 
subgroups, we were unable to analyse patients with rheumatoid 
and osteoarthritis separately to determine if there were any differences in outcome 
relative to the underlying pathology. 
 
In this series, the WOMAC score was not significantly different between any of the 
postoperative time points suggesting that recovery from TKR, as assessed by the 
WOMAC, plateaus at around three months after surgery. In contrast, the OKS 
improved significantly from three months to one year postoperation. This suggests 
that three months would appear to be too early a time point to judge the outcome 
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of TKR when measured by the OKS. This supports data suggesting that the 6 month 
outcome according to the OKS is an acceptable time point to assess patient reported 
outcomes after TKR [21]. The patients in this reported cohort achieved absolute 
changes in OKS (>11) and final OKS scores (>30) in the early postoperative period 
which are correlated with high levels of satisfaction and these outcomes were 
maintained in the long term [21]. Despite this, we observed a significant decline in 
patient satisfaction over the period of the study. Whilst our interpretation of this 
phenomenon is limited by the small final sample size, it suggests that patient 
satisfaction is a more complex outcome than may be assumed and it may not be 
accurately determined or substituted for by the use of outcome scores such as the 
WOMAC or OKS. It has been suggested that patient related outcome scores may be a 
more sensitive measure for pain and quality of life in TKR [22]. 
 
The most frequent complication observed in the series was anterior knee pain with 
11 out of 39 patients reporting this at final follow up. The majority of patients in this 
study had their patella resurfaced at the time of the primary surgery but there were 
no revisions performed due to patellar component failure alone in contrast to other 
series [23]. The incidence of anterior knee pain in our series was higher than in 
Ewald et al.’s study. The resurfacing or not of the patella is not the sole determinant 
of anterior knee pain and related function following TKR; femoral component design, 
malrotation of components, oversizing and offset errors are correlated with anterior 
knee pain [24].  
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Weaknesses of this study include the small number of patients from the original 
cohort alive at the time of the final follow up, which limits our ability to interpret 
certain changes over time such as the decline in patient reported satisfaction despite 
well maintained functional scores. For patients that were deceased, we queried local 
hospital and primary care records to ascertain of a revision had occurred. In the NHS, 
the primary care clinician acts as a gatekeeper for access to secondary care services 
and there is an obligation for secondary care clinicians to inform the primary care 
clinician of treatment and interventions. Whilst we are confident that this method 
allows for robust data capture of revision episodes, this is not a formally validated 
method and there is the possibility that we may have missed revision episodes, this 
is reflected in the confidence intervals of our survival estimates. The implantations 
predate the National Joint Registry in the NHS and there was no alternative suitable 
national database available to determine if revision had occurred. We were required 
to exclude a small number of patients due to comorbidities that rendered them 
incapable of completing the postal questionnaire but our follow up proportion of 
surviving patients is comparable to other long terms follow up studies [6]. A further 
strength of the study was the inclusion of preoperative and early postoperative 
scores. Radiological assessment was not performed as part of this study; this leaves 
the possibility that there may be some patients that would be classified as 
radiological failures of whom we are unaware. Of note, none of the patients in the 
final follow up cohort indicated that they had any problems with their TKR that they 
would seek further treatment for or requested further clinical review rendering 
revision surgery in this elderly population unlikely. Range of motion (ROM) was not 
assessed at final follow-up but ROM is known to have only moderate correlation 
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with functional scores and to correlate poorly with patient satisfaction and 
improvements in quality of life [25].  
 
5 Conclusion 
We observed an 84% survivorship of the Kinemax TKR at a follow up of 16.3 years. 
The predominant modes of failure were wear and loosening. Functional scores were 
in excess of the identified thresholds that correlate with high levels of patient 
satisfaction in large sample sizes and these improvements were maintained in the 
long term although satisfaction did decline with time.  
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Table 1 
 
 
 Preop Postop 
3 months 1 year 2 years 15.7 years 
WOMAC 
pain 
subscale 
12 
(10-14) 
4 
(2-6) 
2 
(0-6) 
2 
(0-5) 
5 
(0.75-7.25) 
WOMAC 
function 
subscale 
37 
(29-44) 
21 
(11.25-
29.75) 
17 
(6.25-30) 
15 
(8-30.5) 
24 
(5.75-
35.25) 
WOMAC 
stiffness 
subscale 
4 
(3-5) 
3 
(2-4) 
* * 2 
(1-4) 
WOMAC 
global 
score 
52 
(44-63) 
27 
(16.5-38) 
+ + 33 
(10.5-42.5) 
OKS 16 
(12-22) 
30 
(19.5-34.5) 
34 
(28-41.25) 
34 
(26.5-41) 
31.5 
(23-39.5) 
SAPS ! 93.75 
(81.25-100) 
93.75 
(81.25-100) 
100 
(81.25-100) 
75 
(50-100) 
 
Table 1: WOMAC, OKS and SAPS preoperatively, at 3 months, 1 year, 2 years and 
15.7 years postoperation (* WOMAC stiffness subscale unavailable at 1 and 2 years 
postoperation; + WOMAC global score not calculated at 1 and 2 years due to lack of 
stiffness subscale; ! SAPS not relevant preoperatively) 
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